Results 151 to 160 of about 3,595 (167)

Dalbavancin

2010
Aryun Kim, Joseph Kuti, David Nicolau
openaire   +1 more source

Comparing two-dose 1500 mg dalbavancin to standard of care in the outpatient treatment of invasive infections

Drugs & therapy perspectives
Rachel Friend, Trey Willoughby, Elizabeth W. Covington, S. Gunter   +3 more
semanticscholar   +1 more source

Dalbavancin

2009
openaire   +1 more source

Dalbavancin

Reactions Weekly, 2018
openaire   +2 more sources

Dalbavancin

2017
openaire   +1 more source

Exploring the subcutaneous route for dalbavancin administration in a long-term suppressive therapy of orthopaedic device-related infection.

International Journal of Antimicrobial Agents
Paula Pons-Oltra, E. Benavent, Miriam Maireles, M. Ulldemolins, R. Rigo‐Bonnin, Oscar Murillo   +5 more
semanticscholar   +1 more source

Dalbavancin/vancomycin

Reactions Weekly, 2022
openaire   +1 more source

Dalbavancin as suppressive therapy for implant-related infections: a case series with therapeutic drug monitoring and review of the literature

European Journal of Clinical Microbiology and Infectious Diseases
Barthélémy Lafon-Desmurs, Benoît Gachet, B. Hennart, Benjamin Valentin, Gabrielle Roosen, Maxime Degrendel, C. Loiez, É. Beltrand, P. D'elia, H. Migaud, O. Robineau, E. Senneville   +11 more
semanticscholar   +1 more source

Avibactam/ceftazidime/cotrimoxazole/dalbavancin

Reactions weekly

semanticscholar   +1 more source

Dalbavancin

2016
openaire   +1 more source